Clinical trial
Evaluation of the Performance and Safety of Polydioxanone Suture (PDO) "Bio Meyisun" for the Temporary Correction of the Mid-face Area.
NCT07068061 is registered in ClinicalTrials.gov with 21 Century Medical Co., Ltd. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Evaluation of the Performance and Safety of Polydioxanone Suture (PDO) "Bio Meyisun" for the Temporary Correction of the Mid-face Area.
- Lead sponsor
- 21 Century Medical Co., Ltd.
- Phase
- Not applicable
- Overall status
- Not yet recruiting
- Start date
- September 1, 2025
- Completion date
- July 1, 2026
- Enrollment
- 50 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
anti aging, face-lift, wrinkles